Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
445.2 USD | +1.04% | +5.31% | +9.42% |
05-15 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
05-14 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B | |
-24.95% | 8.45B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q1 2019 Earnings Call, Apr 30, 2019